168 results
Page 3 of 9
8-K
EX-99.1
bqtqf i83ds77nbf33
9 Nov 22
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
4:20pm
8-K
EX-99.1
1x83y 2wb
26 Oct 22
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
4:30pm
8-K
EX-99.1
1841aivst0g
10 Aug 22
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
5:22pm
8-K
EX-99.1
t3v3iu1i
6 Jul 22
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
4:30pm
8-K
0mfly
6 Jul 22
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
4:30pm
8-K
EX-10.2
o19f80bugnl iscfr
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
5w2vvsbo 7bvlt05lzc3
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.2
7731 2qcwap7fojd
25 May 22
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
u0u7mucha1v330
25 May 22
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
jpijlfnfcbdae4xb
19 May 22
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
em7fnasdhb
4 May 22
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results
4:41pm
8-K
EX-99.1
rzs h2c6v1z
14 Mar 22
DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results
4:58pm